Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

A Russian missile strike has destroyed $2.6m (£1.9m) worth of HIV prevention supplies in Ukraine, according to an ...

Gilead Sciences & Merck announce investigational once-weekly oral HIV treatment regimen of islatravir and lenacapavir maintained virological suppression in adults with HIV who swi ...

Gilead Sciences and MSD's once-weekly oral medicine for HIV has been shown to achieve high rates of viral load suppression in ...

On 8 July, Dr Fred Nana Poku, Director of Technical Services at the Ghana AIDS Commission, told the country that 1,200 babies ...

As the global HIV response faces shrinking funding, increasing pressure on civil society, and growing attacks on human rights and gender equality, UNAIDS' Eamonn Murphy has called for communities to ...

The Commission on Human Rights (CHR) and youth health advocates on Tuesday called for an end to HIV-related stigma as the ...

Gilead Sciences and Merck said on Tuesday their experimental once-weekly HIV pill kept the virus suppressed in two late-stage ...

HIV treatment has progressed significantly since the 1980s. ART enables viral suppression and prevents transmission, but HIV ...

Michael Hendricks (1941-2026), a foundational figure in Montreal HIV/AIDS activism, a prominent LGBTQ+ rights advocate and ...

Gilead and Merck today (Tuesday, July 21) announced new results from the Phase 3 ISLEND-1(NCT06630286) ...

Today is Zero HIV Stigma Day. On 8 July, Dr Fred Nana Poku, Director of Technical Services at the Ghana AIDS Commission, told ...